Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012–2016

Fernández-Ávila, Daniel G.; Bernal-Macías, Santiago; Rincón-Riaño, Diana N.; Gutiérrez, Juan Martín; Rosselli, Diego

doi:10.1007/s00296-019-04387-5

Cited by 10 publications

(6 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This approach is similar to the ones proposed in other studies that have used data from SIS-PRO to estimate the prevalence of other diseases in Colombia [24][25][26][27][28][29][30].…”

Section: Methodsmentioning

confidence: 89%

Prevalence of sleep apnea in children and adolescents in Colombia according to the national health registry 2017–2021

et al. 2022

View full text Add to dashboard Cite

Objective To describe the sociodemographic and epidemiological characteristics of diagnosis and treatment of pediatric patients with sleep apnea, both central and obstructive, in Colombia between 2017 and 2021. Methods Observational, descriptive, cross-sectional, epidemiological study using the International Classification of Diseases and Related Health Problems as search terms for sleep apnea, based on SISPRO, the Colombian national health registry. Stratification by gender and age groups was performed. We also generated data of the amount of diagnostic and therapeutic procedures performed. A map of prevalence by place of residency was performed. Results National records report 15200 cases of SA between 2017 and 2021, for an estimated prevalence of 21.1 cases by 100000 inhabitants in 2019 the year with the most cases (4769), being more frequent and in the 6 to 11 age group and in males, with a male to female ratio of 1.54:1. The number of cases declined in 2020 and 2021. The map showed a concentration of cases in the more developed departments of the country. Discussion This is the first approximation to a nation-wide prevalence of sleep apnea in Colombia which is lower to what is found in the literature worldwide, including studies performed in Latin America and in Colombia, this could reflect sub diagnosis and sub report. The fact that the highest prevalence was found in males and in the 6–11 age group is consistent with reports in literature. The decrease in cases in 2020 and 2021 could be related to the COVID-19 pandemic impact in sleep medicine services.

show abstract

“…This approach is similar to the ones proposed in other studies that have used data from SIS-PRO to estimate the prevalence of other diseases in Colombia [24][25][26][27][28][29][30].…”

Section: Methodsmentioning

confidence: 89%

Prevalence of sleep apnea in children and adolescents in Colombia according to the national health registry 2017–2021

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The Ministry of Health and Social Security developed the SISPRO tool for storing and processing the basic information needed for guiding, regulating and monitoring the general health social security system processes. The SISPRO tool consolidates and provides information through several components including the Single Registry of Enrollees (RUAF in Spanish), Healthcare Information System (RIPS in Spanish), Integrated Spreadsheet of Payments to the System (PILA in Spanish), Hospital Management System (SIHO in Spanish), Data Management System (SGD in Spanish), Drug Price Information System (SISMED in Spanish), and My Prescription (MIPRES in Spanish), among others [8][9][10] .…”

Section: Methodsmentioning

confidence: 99%

Frequency and geographical distribution of the use of sacubitril/valsartan in Colombia between 2019 and 2020

Herrera-Leaño,

Barahona-Correa,

Muñoz-Velandia

et al. 2024

RCCARE

View full text Add to dashboard Cite

Introduction:Real-life adherence to the management of heart failure is suboptimal. Adherence to the recommendations for the use of sacubitril/valsartan in Colombia is unknown. Objective: To assess the frequency of use, geographic distribution, and demographic characteristics of patients who were prescribed sacubitril/valsartan in 2019-2020, using data from the "Sistema Integrado de Información de Protección Social" (SISPRO). Materials and method: This is a descriptive cross-sectional study. Information was extracted on the prescription distribution by department, gender, five-year age group and the ICD-10 codes with which the medication was prescribed. Results: Between 2019 and 2020, 23,026 patients in Colombia were prescribed sacubitril/valsartan; 63.86% of the patients were men. Ninety-two percent of the prescriptions were for patients over the age of 50. The regions of the country with the highest prescription frequency were Bogotá, Sucre and Santander. Conclusions: Taking into account the estimated prevalence of heart failure (2-3%), the frequency with which sacubitril/valsartan is prescribed in Colombia is lower than expected. The rural regions of the country have the lowest use, which suggests access barriers that should be explored.

show abstract

“…El Ministerio de Salud y Protección Social desarrolló la herramienta SISPRO para el almacenamiento y procesamiento de la información básica requerida para la dirección, regulación y control de los procesos del sistema general de seguridad social en salud. SISPRO consolida y dispone información a través de múltiples componentes como: RUAF (Registro único de afiliados), RIPS (Sistema de Información de Prestaciones de Salud), PILA (Planilla Integrada de Liquidación de Aporte), SIHO (Sistema de Gestión Hospitalaria), SGD (Sistema de Gestión de Datos), SISMED (Sistema de Información de Precios de Medicamentos), MIPRES (Mi Prescripción), entre otros [8][9][10] .…”

Section: Materiales Y Métodounclassified

Frecuencia y distribución geográfica del uso de sacubitril/valsartán en Colombia entre los años 2019 y 2020

Herrera-Leaño,

Barahona-Correa,

Muñoz-Velandia

et al. 2024

RCCAR

View full text Add to dashboard Cite

características demográficas de los pacientes a quienes se les formuló sacubitril/valsartán en 2019-2020, utilizando los datos del Sistema Integrado de Información de Protección Social (SISPRO). Materiales y método: Estudio descriptivo de corte transversal, en el que se extrajo la información relativa a la distribución de la prescripción del medicamento por departamento, género, quinquenio de edad y los códigos CIE-10 con los cuales se indicó. Resultados: Entre los años 2019 y 2020, se prescribieron 23.026 pacientes con sacubitril/valsartán en Colombia, de los cuales el 63.86% fueron hombres. El 92% de las prescripciones se hicieron a pacientes mayores de 50 años. Las regiones del país con mayor frecuencia de prescripción fueron Bogotá, Sucre y Santander. Conclusiones: Con base en la prevalencia estimada de falla cardiaca (2 a 3%), la frecuencia de formulación de sacubitril/valsartán en Colombia es menor a la esperada. Las regiones rurales del país son las que presentan el menor uso, lo que sugiere barreras de acceso que deben ser exploradas.

show abstract

Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012–2016

Cited by 10 publications

References 13 publications

Prevalence of sleep apnea in children and adolescents in Colombia according to the national health registry 2017–2021

Prevalence of sleep apnea in children and adolescents in Colombia according to the national health registry 2017–2021

Frequency and geographical distribution of the use of sacubitril/valsartan in Colombia between 2019 and 2020

Frecuencia y distribución geográfica del uso de sacubitril/valsartán en Colombia entre los años 2019 y 2020

Contact Info

Product

Resources

About